Viewing Study NCT01279850


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-01-29 @ 2:52 AM
Study NCT ID: NCT01279850
Status: COMPLETED
Last Update Posted: 2023-10-10
First Post: 2011-01-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A0081262
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators